Global and Europe Active Pharmaceutical Ingredients Market - Analysis and Outlook to 2022
This report presents a comprehensive overview of the Active Pharmaceutical Ingredients market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.
This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Active Pharmaceutical Ingredients industry.
This report focuses on Global and Europe market, including details as following:
Key Players
Pfizer, Inc. (U.S.)
Novartis International AG (Switzerland)
Sanofi (France)
Boehringer Ingelheim (Germany)
Bristol-Myers Squibb (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (U.S.)
GlaxoSmithKline plc (U.K.)
Merck & Co., Inc. (U.S.)
AbbVie Inc. (U.S.)
Key Regions
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Poland
Others
United States
China
Japan
India
Others
Key Product Type
Key Product Type
by market Type
Innovative APIs
Generic APIS
Other
by Type of Manufacturer
Captive Manufacturers
Merchant Manufacturers
Other
by Type of Drug
Prescription Drugs
Over-the-counter Drugs
Other
by Therapeutic Application
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders,
Other
Key Applications
Hospital
Medical Center
Other
This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Active Pharmaceutical Ingredients industry.
This report focuses on Global and Europe market, including details as following:
Key Players
Pfizer, Inc. (U.S.)
Novartis International AG (Switzerland)
Sanofi (France)
Boehringer Ingelheim (Germany)
Bristol-Myers Squibb (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (U.S.)
GlaxoSmithKline plc (U.K.)
Merck & Co., Inc. (U.S.)
AbbVie Inc. (U.S.)
Key Regions
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Poland
Others
United States
China
Japan
India
Others
Key Product Type
Key Product Type
by market Type
Innovative APIs
Generic APIS
Other
by Type of Manufacturer
Captive Manufacturers
Merchant Manufacturers
Other
by Type of Drug
Prescription Drugs
Over-the-counter Drugs
Other
by Therapeutic Application
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders,
Other
Key Applications
Hospital
Medical Center
Other
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
